MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacl.2026.09.009

Медицинская библиотека · Journal of clinical lipidology · 2026

Does the evidence support the ACC/AHA multisociety recommendation to measure apoB only after LDL-C and non-HDL-C are at target?

Cole Justine, Dufresne Line, Toth Peter P, Langlois Michel, Thanassoulis George, Sniderman Allan D

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The American College of Cardiology (ACC)/American Heart Association (AHA) multisociety guidelines, state that discordance between apolipoprotein B (apoB) and Martin/Hopkins (MH) low-density lipoprotein cholesterol (LDL-C) is minimal at LDL-C targets of 100 and 70 mg/dL, citing studies that did not use the guideline's apoB targets.

OBJECTIVE

We aimed to quantify discordance at the recommended apoB targets, which correspond to values from uncited studies, and at population-equivalent values, and to determine the clinical significance of that discordance.

METHODS

Variance between LDL-C estimated by MH, modified-Sampson (mS), or Friedewald (F) and apoB was examined in the National Health and Nutrition Examination Survey (NHANES) database. Differences between achieving guideline targs of MH LDL-C, mS LDL-C, and F LDL-C vs guideline target levels of apoB (90, 70, and 55 mg/dL) or the percentile equivalent values of apoB in the untreated NHANES-based population (79, 58, and 46 mg/dL) were calculated. Clinical significance of discordance of MH-LDL-C was determined in the UK Biobank overall and at the 3 target levels of MH LDL-C.

RESULTS

Significant discordance was present between LDL-C, however estimated, and apoB in the NHANES participants. Substantial differences between apoB and LDL-C at target levels were evident using guideline target values of apoB and even greater using population equivalent values of apoB. In the UK Biobank, residual discordance analysis demonstrated apoB was a more precise marker of cardiovascular risk than MH LDL-C overall and at MH LDL-C target levels of LDL-C of 100 and 70 mg/dL.

CONCLUSION

This report identifies an apparent consequential error in the ACC/AHA multisociety guidelines and further supports the view that apoB should have at least equal priority to LDL-C and non-high-density lipoprotein cholesterol in routine clinical care.

Для цитирования: Cole Justine, Dufresne Line, Toth Peter P, Langlois Michel, Thanassoulis George, Sniderman Allan D. Does the evidence support the ACC/AHA multisociety recommendation to measure apoB only after LDL-C and non-HDL-C are at target?. Journal of clinical lipidology. 2026. DOI: 10.1016/j.jacl.2026.09.009.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.